Skip to content

A multicenter randomized controlled trial to evaluate the length of hospital stay of intracorporeal versus extracorporeal anastomosis in laparoscopic colectomy for colon cancer

A multicenter randomized controlled trial to evaluate the length of hospital stay of intracorporeal versus extracorporeal anastomosis in laparoscopic colectomy for colon cancer - CONNECT study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041565
Enrollment
300
Registered
2020-09-01
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

intracorporeal end-to-end anastomosis intracorporeal side-to-side anastomosis extracorporeal anastomosis

Sponsors

Gastroenterological Center, Yokohama City University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with preoperative histologically diagnosed colon cancer (including adenocarcinoma, squamous cell carcinoma, adenosquamous cell carcinoma, and neuroendocrine tumors) (2) Patients with tumors in the cecum, ascending colon, transverse colon, descending colon, or sigmoid colon and scheduled for laparoscopic colon resection. (3) Patients with a maximum tumor diameter of 8 cm or less (4) Patients with a preoperative clinical diagnosis of Stage I-III (5) Patients with ECOG Performance Status of grade 0 to 2

Exclusion criteria

Exclusion criteria: (1) Patients who have had a previous colorectal resection (2) Patients who are scheduled to undergo anastomosis with the Double Stapling Technique (3) Patients who are scheduled to have a stoma (or who will have a stoma remaining after the operation if it was already in place before the operation) (4) Patients with bowel obstruction (5) Patients scheduled to undergo simultaneous resection of multiple organs due to duplicate cancer (6) Patients scheduled to have more than one anastomosis due to multiple colorectal cancers. (7) Patients with active intra-abdominal infections (8) Patients with uncontrolled severe comorbidity (9) Other patients who are deemed by the attending physician to be unable to participate in the research.

Design outcomes

Primary

MeasureTime frame
length of postoperative stay

Secondary

MeasureTime frame
time required for anastomosis

Countries

Japan

Contacts

Public ContactShogo Takei

Yokohama City University Medical Center Gastroenterological Center

shogot@yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026